Recent MSK Discoveries & Advances

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
385 News Items found
Illustration of girl standing in front of charging bull
In Brief
Scientists Identify How Gene Mutation Drives a Deadly Childhood Cancer

Synovial sarcoma is an aggressive cancer primarily affecting children and young adults. A new study gets to the bottom of it.
Illustration of a female doctor touching a strand of DNA
In the Clinic
New MSK Initiative Focuses on the Early Detection and Prevention of Cancer

Because cancer is more treatable when it’s caught early, MSK’s new Precision Interception and Prevention initiative focuses on early detection.
Molecular model of olaparib
Q&A
The Latest on Genetic Testing for BRCA Mutations in Breast Cancer

An MSK medical oncologist and geneticist discusses the latest drug approved for breast cancer and how genetic testing can lead to new treatments.
Bob Fontaine (with daughter Mariah, mother Margaret, and wife Ann) credits Dr. Ariyan's trial with saving his life.
In the Clinic
After Isolated Limb Infusion, People with Melanoma Get a Second Chance at Life

Meet three people who were treated as part of a clinical trial for melanoma at Memorial Sloan Kettering.
Jedd Wolchok and Charlotte Ariyan in the lab
In the Clinic
Chemotherapy-Immunotherapy Combination Aims to Knock Out Melanoma with a One-Two Punch

A new approach for treating melanoma combines the immunotherapy drug ipilimumab with chemotherapy that treats only the area affected by cancer.
Medical oncologist Jae Park
In the Clinic
Longest-Running CAR T Trial Shows Which Patients Benefit Most, Have Fewest Side Effects

The study represents 20 years of research at MSK.
A yellow molecular model of the androgen receptor on brown background
In the Clinic
An Unlikely Treatment for Triple-Negative Breast Cancer: Prostate Cancer Drugs

Doctors are developing treatment strategies that target the androgen receptor, which is found in many triple-negative breast cancers.
abstract red and blue lines suggestive of metabolic pathways
In the Lab
Scientists Create First-of-Its-Kind Metabolic Road Map of Cancer

The online resource will serve as a benchmark for researchers studying metabolism and cancer.
Physician-scientist Ross Levine and research technician Aishwarya Krishnan speak in the lab
In the Clinic
MSK Opens New Clinic to Monitor People with a Genetic Risk for Developing Blood Cancer

MSK's new clinic will focus on clonal hematopoiesis, a condition related to aging that increases the risk of developing certain blood cancers.
A gray blob marked RAS linked to colorful rods marked ICMT
In the Lab
Deciphering How Membrane Enzymes Work, with a Little Help from Beetles

The atomic structure of an elusive type of membrane protein has finally been solved by scientists at the Sloan Kettering Institute.